CYLD and neoplasm: To further evaluate the prediction power of candidate biomarkers that have greater likelihoods of becoming clinically useful markers for NPC diagnosis and for monitoring tumor progression, we built multiple logistic regression models considering the expression of CDH4, STAT4, CYLD and LMP1.